| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 22342 | 2016 |
| Heart disease and stroke statistics—2010 update: a report from the American Heart Association Writing Group Members, D Lloyd-Jones, RJ Adams, TM Brown, ... Circulation 121 (7), e46-e215, 2010 | 14990* | 2010 |
| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 11198 | 2017 |
| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... Circulation 129 (3), e28-e292, 2014 | 9576 | 2014 |
| Heart disease and stroke statistics—2019 update: a report from the American Heart Association EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Circulation 139 (10), e56-e528, 2019 | 9349 | 2019 |
| Update A Report From the American Heart--Heart Disease and Stroke Statistics AS Go, D Mozaffarian, VL Roger Circulation 127, 6-245, 2013 | 9218* | 2013 |
| Heart disease and stroke statistics—2018 update: a report from the American Heart Association EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ... Circulation 137 (12), e67-e492, 2018 | 7882 | 2018 |
| Heart disease and stroke statistics—2012 update: a report from the American Heart Association Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ... Circulation 125 (1), e2-e220, 2012 | 7777 | 2012 |
| Heart disease and stroke statistics—2011 update: a report from the American Heart Association VL Roger, AS Go, DM Lloyd-Jones, RJ Adams, JD Berry, TM Brown, ... Circulation 123 (4), e18-e209, 2011 | 7487 | 2011 |
| Dapagliflozin and cardiovascular outcomes in type 2 diabetes SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ... New England Journal of Medicine 380 (4), 347-357, 2019 | 6615 | 2019 |
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ... New England Journal of Medicine 369 (14), 1317-1326, 2013 | 4360 | 2013 |
| Heart disease and stroke statistics-2003 update American Heart Association http://www. americanheart. org/downloadable/heart …, 2002 | 3587 | 2002 |
| American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ... Heart disease and stroke statistics-2018 update: a report from the American …, 2018 | 3324 | 2018 |
| Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ... New England Journal of Medicine 373 (3), 232-242, 2015 | 3281 | 2015 |
| Heart disease and stroke statistics: 2006 update American Heart Association http://circ. ahajournals. org/cgi/reprint/CIRCULATIONAHA. 105.171600 v1, 2006 | 3091* | 2006 |
| SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome … TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ... The Lancet 393 (10166), 31-39, 2019 | 2881 | 2019 |
| Executive summary: Heart disease and stroke statistics-2012 update: A report from the American Heart Association R Blumenthal Circulation 125 (1), 188-97, 2012 | 2021 | 2012 |
| Sotagliflozin in patients with diabetes and recent worsening heart failure DL Bhatt, M Szarek, PG Steg, CP Cannon, LA Leiter, DK McGuire, ... New England journal of medicine 384 (2), 117-128, 2021 | 1732 | 2021 |
| B-type natriuretic peptide in cardiovascular disease JA de Lemos, DK McGuire, MH Drazner The Lancet 362 (9380), 316-322, 2003 | 1675 | 2003 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1555 | 2018 |
